Document Detail


Intra-arterial adriamycin chemotherapy for bladder cancer. Semiselective intra-arterial chemotherapy with compression of the femoral arteries at the time of injection.
MedLine Citation:
PMID:  6640836     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Twenty patients with bladder cancer were treated by semiselective intra-arterial chemotherapy with Adriamycin. Ten of them were given the agent while the femoral arteries were compressed, to prevent loss of the agent into the external iliac arteries. The other ten were given Adriamycin without this compression. Clinical and pathological responses of tumor and the side-effects were examined in these two groups. The results of the comparative study led us to the conclusion that the compression technique is a simple and valuable means of decreasing the side-effects of Adriamycin and increasing tumor response.
Authors:
T Uyama; S Moriwaki; M Yonezawa; J Fujita
Related Documents :
23555466 - Simultaneous evaluation of the whole aorta and artery of adamkiewicz by mdct.
21560816 - Aortic valve repair of non-penetrating traumatic aortic regurgitation.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cancer chemotherapy and pharmacology     Volume:  11 Suppl     ISSN:  0344-5704     ISO Abbreviation:  Cancer Chemother. Pharmacol.     Publication Date:  1983  
Date Detail:
Created Date:  1984-01-27     Completed Date:  1984-01-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7806519     Medline TA:  Cancer Chemother Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  S59-63     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoma, Transitional Cell / drug therapy*,  pathology,  radiography
Constriction
Doxorubicin / administration & dosage*,  adverse effects
Female
Femoral Artery
Humans
Injections, Intra-Arterial / methods
Male
Middle Aged
Urinary Bladder Neoplasms / drug therapy*,  pathology,  radiography
Chemical
Reg. No./Substance:
23214-92-8/Doxorubicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term intra-arterial infusion chemotherapy with adriamycin for advanced bladder cancer.
Next Document:  Intravesical chemotherapy in urinary bladder cancer.